Nature of Cardiac Rehabilitation Around the Globe.
Cardiac rehabilitation
Global health
Health services
Nature
Preventive cardiology
Survey
Journal
EClinicalMedicine
ISSN: 2589-5370
Titre abrégé: EClinicalMedicine
Pays: England
ID NLM: 101733727
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
received:
02
01
2019
revised:
12
06
2019
accepted:
12
06
2019
entrez:
14
9
2019
pubmed:
14
9
2019
medline:
14
9
2019
Statut:
epublish
Résumé
Cardiac rehabilitation (CR) is a clinically-effective but complex model of care. The purpose of this study was to characterize the nature of CR programs around the world, in relation to guideline recommendations, and compare this by World Health Organization (WHO) region. In this cross-sectional study, a piloted survey was administered online to CR programs globally. Cardiac associations and local champions facilitated program identification. Quality (benchmark of ≥ 75% of programs in a given country meeting each of 20 indicators) was ranked. Results were compared by WHO region using generalized linear mixed models. 111/203 (54.7%) countries in the world offer CR; data were collected in 93 (83.8%; N = 1082 surveys, 32.1% program response rate). The most commonly-accepted indications were: myocardial infarction (n = 832, 97.4%), percutaneous coronary intervention (n = 820, 96.1%; 0.10), and coronary artery bypass surgery (n = 817, 95.8%). Most programs were led by physicians (n = 680; 69.1%). The most common CR providers (mean = 5.9 ± 2.8/program) were: nurses (n = 816, 88.1%; low in Africa, p < 0.001), dietitians (n = 739, 80.2%), and physiotherapists (n = 733, 79.3%). The most commonly-offered core components (mean = 8.7 ± 1.9 program) were: initial assessment (n = 939, 98.8%; most commonly for hypertension, tobacco, and physical inactivity), risk factor management (n = 928, 98.2%), patient education (n = 895, 96.9%), and exercise (n = 898, 94.3%; lower in Western Pacific, p < 0.01). All regions met ≥ 16/20 quality indicators, but quality was < 75% for tobacco cessation and return-to-work counseling (lower in Americas, p = < 0.05). This first-ever survey of CR around the globe suggests CR quality is high. However, there is significant regional variation, which could impact patient outcomes.
Sections du résumé
BACKGROUND
BACKGROUND
Cardiac rehabilitation (CR) is a clinically-effective but complex model of care. The purpose of this study was to characterize the nature of CR programs around the world, in relation to guideline recommendations, and compare this by World Health Organization (WHO) region.
METHODS
METHODS
In this cross-sectional study, a piloted survey was administered online to CR programs globally. Cardiac associations and local champions facilitated program identification. Quality (benchmark of ≥ 75% of programs in a given country meeting each of 20 indicators) was ranked. Results were compared by WHO region using generalized linear mixed models.
FINDINGS
RESULTS
111/203 (54.7%) countries in the world offer CR; data were collected in 93 (83.8%; N = 1082 surveys, 32.1% program response rate). The most commonly-accepted indications were: myocardial infarction (n = 832, 97.4%), percutaneous coronary intervention (n = 820, 96.1%; 0.10), and coronary artery bypass surgery (n = 817, 95.8%). Most programs were led by physicians (n = 680; 69.1%). The most common CR providers (mean = 5.9 ± 2.8/program) were: nurses (n = 816, 88.1%; low in Africa, p < 0.001), dietitians (n = 739, 80.2%), and physiotherapists (n = 733, 79.3%). The most commonly-offered core components (mean = 8.7 ± 1.9 program) were: initial assessment (n = 939, 98.8%; most commonly for hypertension, tobacco, and physical inactivity), risk factor management (n = 928, 98.2%), patient education (n = 895, 96.9%), and exercise (n = 898, 94.3%; lower in Western Pacific, p < 0.01). All regions met ≥ 16/20 quality indicators, but quality was < 75% for tobacco cessation and return-to-work counseling (lower in Americas, p = < 0.05).
INTERPRETATION
CONCLUSIONS
This first-ever survey of CR around the globe suggests CR quality is high. However, there is significant regional variation, which could impact patient outcomes.
Identifiants
pubmed: 31517262
doi: 10.1016/j.eclinm.2019.06.006
pii: S2589-5370(19)30099-9
pmc: PMC6733999
doi:
Types de publication
Journal Article
Langues
eng
Pagination
46-56Déclaration de conflit d'intérêts
Dr. Derman reports some financial activities that were outside the submitted work (i.e., grants from International Olympic and Paralympic Committees, as well as personal fees from 2 advisory boards). All other authors declare no financial or personal interests related to the work.
Références
Can J Cardiol. 2014 Nov;30(11):1452-5
pubmed: 25442441
Circulation. 2011 Dec 6;124(23):e652-735
pubmed: 22064599
Prog Cardiovasc Dis. 2017 Sep - Oct;60(2):267-280
pubmed: 28844588
Eur J Prev Cardiol. 2016 Nov;23(16):1715-1733
pubmed: 27353128
Heart. 2013 Aug;99(15):1069-71
pubmed: 23403407
J Cardiopulm Rehabil Prev. 2011 Jan-Feb;31(1):2-10
pubmed: 21217254
Eur J Prev Cardiol. 2014 Jun;21(6):664-81
pubmed: 22718797
Cochrane Database Syst Rev. 2017 Apr 04;4:CD012264
pubmed: 28375548
Circ Cardiovasc Qual Outcomes. 2020 Jan;13(1):e005453
pubmed: 31918580
Scand J Med Sci Sports. 2015 Dec;25 Suppl 3:1-72
pubmed: 26606383
BMC Health Serv Res. 2016 Sep 06;16:471
pubmed: 27600379
Open Heart. 2017 Jan 09;4(1):e000519
pubmed: 28123763
Cochrane Database Syst Rev. 2019 Jan 29;1:CD003331
pubmed: 30695817
Nat Rev Cardiol. 2014 Oct;11(10):586-96
pubmed: 25027487
Circulation. 2007 May 22;115(20):2675-82
pubmed: 17513578
Circulation. 2011 Nov 29;124(22):2458-73
pubmed: 22052934
Inquiry. 1988 Spring;25(1):173-92
pubmed: 2966122
J Am Coll Cardiol. 2016 Jan 5;67(1):1-12
pubmed: 26764059
J Cardiopulm Rehabil Prev. 2013 Jan-Feb;33(1):33-41
pubmed: 23235320
J Am Coll Cardiol. 2011 Dec 6;58(24):e44-122
pubmed: 22070834
Can J Cardiol. 2014 Aug;30(8):945-8
pubmed: 25064585
J Am Coll Cardiol. 2007 Oct 2;50(14):1400-33
pubmed: 17903645
Cochrane Database Syst Rev. 2017 Feb 09;2:CD011197
pubmed: 28181684
J Cardiovasc Med (Hagerstown). 2012 Nov;13(11):727-34
pubmed: 22885529
Circulation. 1998 Jun 9;97(22):2283-93
pubmed: 9631884
EClinicalMedicine. 2019 Jul 03;13:31-45
pubmed: 31517261
Eur J Prev Cardiol. 2017 Oct;24(15):1596-1609
pubmed: 28762761
Glob Heart. 2017 Dec;12(4):323-334.e10
pubmed: 28302548
Heart Lung Circ. 2015 May;24(5):430-41
pubmed: 25637253
Eur Heart J. 2013 Oct;34(38):2949-3003
pubmed: 23996286
J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239
pubmed: 23747642
Eur J Cardiovasc Prev Rehabil. 2010 Aug;17(4):410-8
pubmed: 20300001
BMC Health Serv Res. 2015 Nov 26;15:521
pubmed: 26607235
Heart. 2016 Sep 15;102(18):1449-55
pubmed: 27181874
J Clin Med. 2018 Sep 07;7(9):
pubmed: 30205461
Cochrane Database Syst Rev. 2016 Mar 21;3:CD010876
pubmed: 26998683